Quinlan Steven J. 4
4 · NEOGEN CORP · Filed Jan 7, 2021
Insider Transaction Report
Form 4
NEOGEN CORPNEOG
Quinlan Steven J.
VP & CFO
Transactions
- Exercise/Conversion
Common Stock
2021-01-07$40.46/sh+9,333$377,637→ 22,803 total - Sale
Common Stock
2021-01-07$84.49/sh−9,333$788,526→ 13,470 total - Exercise/Conversion
Common Stock (Right to Buy)
2021-01-07−9,333→ 131,999 totalExercise: $40.46Exp: 2021-10-29→ Common Stock (9,333 underlying)
Footnotes (1)
- [F1]Options were issued on 9/29/2016, have five year lives and vest in equal 20% annual installments on each of the first five anniversary dates of the grant